menu ☰
menu ˟

VIDEO: LipiFlow treatment addresses persistent MGD

21 Nov 2016
ANAHEIM, Calif. – Leslie O’Dell, OD, said that meibomian gland dysfunction (MGD) is the cause of symptoms and clinical findings in 86% of her patients, so she uses TearScience’s LipiView and LipiFlow technology to image and treat the meibomian ...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.